Try our Advanced Search for more refined results

January 27, 2020

GENUS LIFESCIENCES, INC. v. AZAR et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 17, 2021

    Genus, Lannett Reach Deal To End Suit Over Cocaine Drug

    A company that accused the U.S. Food and Drug Administration of improperly approving a Lannett Co. application for a cocaine-based numbing agent has told a District of Columbia federal judge that the businesses have tentatively reached a deal to end the lawsuit.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login